Hengrui Pharma Reports Cumulative Share Buyback of 12.06 Million A-Shares by End of May

Stock News06-02

Hengrui Pharma (01276) has issued an announcement regarding its share repurchase activities.

In May 2026, the company did not repurchase any shares through the block trading system of the Shanghai Stock Exchange.

As of May 31, 2026, the cumulative number of shares repurchased under the current buyback program via the block trading system on the Shanghai Stock Exchange reached 12,056,200 shares.

This repurchased volume represents approximately 0.18% of the company's total share capital.

The highest price paid per share was RMB 70.00, while the lowest price paid was RMB 53.52 per share.

The total amount paid for the repurchases was RMB 771.98 million, excluding transaction costs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment